Ceftazidime is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).

• Nosocomial pneumonia
• Broncho-pulmonary infections in cystic fibrosis
• Bacterial meningitis
• Chronic suppurative otitis media
• Malignant otitis externa
• Complicated urinary tract infections
• Complicated skin and soft tissue infections
• Complicated intra-abdominal infections
• Bone and joint infections
• Peritonitis

Pneumonia	Meningitis	Otitis
UTI (Urinary Tract Infection)	Skin Infection	Abdominal Infection

• Ceftazidime dose for adults ranges from 1 to 6 gm per day, administered 8 or 12 hours per day (IM/IV). For the majority of infections, 1 gm 8 hourly or 2 gm 12 hourly should be given.
• Because Ceftazidime clearance is impaired in acutely unwell senior patients, the daily dosage should not exceed 3 gm, especially in those over 80 years old.
• For children over the age of two months, the normal dosage range is 30 to 100 mg/kg/day, divided into two or three doses.

The commonly associated side effects of ceftazidime are-

• Pain at injection site
• Angioedema
• Pruritus
• Rash
• Fever
• Headache
• Dizziness

Pain at injection site	Angioedema	Rash
Fever	Headache	Dizziness

• When Ceftazidime is given to patients with renal impairment, the total daily dose should be lowered.
• Ceftazidime should be used with caution in people who have had gastrointestinal problems, especially colitis.
• Antibacterial agent-associated colitis and pseudo-membranous colitis have been observed with practically all antibacterial drugs, including ceftazidime, and can be mild to fatal.